The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2018

Cerebral small vessel disease burden is associated with poststroke
depressive symptoms: A 15-month prospective study
Yan Liang
Yang-Kun Chen
Vincent C. Mok
De-Feng Wang
Gabor S. Ungvari
The University of Notre Dame Australia, Gabor.Ungvari@nd.edu.au

See next page for additional authors

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Liang, Y., Chen, Y., Mok, V. C., Wang, D., Ungvari, G. S., Chu, W. C., Kang, H., & Tang, W. (2018). Cerebral small vessel disease burden is
associated with poststroke depressive symptoms: A 15-month prospective study. Frontiers in Aging Neuroscience, 10.
Original article available here:
https://doi.org/10.3389/fnagi.2018.00046

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/916. For more
information, please contact researchonline@nd.edu.au.

Authors
Yan Liang, Yang-Kun Chen, Vincent C. Mok, De-Feng Wang, Gabor S. Ungvari, Winnie C. Chu, Hee-Ju Kang,
and Wai-Kwong Tang

This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/med_article/916

This is an Open Access article distributed in accordance with the Creative Commons Attribution 4.0
International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original author and source are credited.
See: https://creativecommons.org/licenses/by/4.0/
This article originally published in Frontiers in Aging Neuroscience available at:
https://doi.org/10.3389/fnagi.2018.00046
Liang, Y., Chen, Y., Mok, V.C., Wang, D., Ungvari, G.S., Chu, W.C., Kang, H., and Tang, W. (2018).
Cerebral small vessel disease burden is associated with poststroke depressive symptoms: A 15month prospective study. Frontiers in Aging Neuroscience, 10. doi: 10.3389/fnagi.2018.00046

ORIGINAL RESEARCH
published: 28 February 2018
doi: 10.3389/fnagi.2018.00046

Cerebral Small Vessel Disease
Burden Is Associated With
Poststroke Depressive Symptoms:
A 15-Month Prospective Study
Yan Liang 1 , Yang-Kun Chen 2 , Vincent Chung-Tong Mok 3 , De-Feng Wang 4 ,
Gabor S. Ungvari 5 , Winnie Chiu-Wing Chu 4 , Hee-Ju Kang 6 and Wai-Kwong Tang 1,7*
1

Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2 Department of Neurology,
Dongguan People’s Hospital, Dongguan, China, 3 Department of Medicine and Therapeutics, The Chinese University of
Hong Kong, Hong Kong, Hong Kong, 4 Department of Imaging and Interventional Radiology, The Chinese University of
Hong Kong, Hong Kong, Hong Kong, 5 Graylands Hospital, The University of Notre Dame Australia, Perth, WA, Australia,
6
Department of Psychiatry, Chonnam National University Hospital, Gwangju, South Korea, 7 Shenzhen Research Institute,
The Chinese University of Hong Kong, Shenzhen, China

Edited by:
Aurel Popa-Wagner,
University of Rostock, Germany
Reviewed by:
Raluca Sandu Vintilescu,
University of Medicine and Pharmacy
of Craiova, Romania
Danny J. J. Wang,
University of Southern California,
United States
*Correspondence:
Wai-Kwong Tang
tangwk@cuhk.edu.hk
Received: 28 November 2017
Accepted: 12 February 2018
Published: 28 February 2018
Citation:
Liang Y, Chen Y-K, Mok VC-T,
Wang D-F, Ungvari GS, Chu WC-W,
Kang H-J and Tang W-K (2018)
Cerebral Small Vessel Disease Burden
Is Associated With Poststroke
Depressive Symptoms: A 15-Month
Prospective Study.
Front. Aging Neurosci. 10:46.
doi: 10.3389/fnagi.2018.00046

Objective: All types of cerebral small vessel disease (SVD) markers including lacune,
white matter hyperintensities (WMH), cerebral microbleeds, and perivascular spaces
were found to be associated with poststroke depressive symptoms (PDS). This study
explored whether the combination of the four markers constituting an overall SVD
burden was associated with PDS.
Methods: A cohort of 563 patients with acute ischemic stroke were followed over
a 15-month period after the index stroke. A score of ≥7 on the 15-item Geriatric
Depression Scale was defined as clinically significant PDS. Scores of the four SVD
markers ascertained on magnetic resonance imaging were summed up to represent
total SVD burden. The association between SVD burden and PDS was assessed with
generalized estimating equation models.
Results: The study sample had a mean age of 67.0 ± 10.2 years and mild-moderate
stroke [National Institutes of Health Stroke Scale score: 3, interquartile, 1–5]. PDS were
found in 18.3%, 11.6%, and 12.3% of the sample at 3, 9, and 15 months after stroke,
respectively. After adjusting for demographic characteristics, vascular risk factors, social
support, stroke severity, physical and cognitive functions, and size and locations of
stroke, the SVD burden was associated with an increased risk of PDS [odds ratio = 1.30;
95% confidence interval = 1.07–1.58; p = 0.010]. Other significant predictors of PDS
were time of assessment, female sex, smoking, number of acute infarcts, functional
independence, and social support.
Conclusion: SVD burden was associated with PDS examined over a 15-month
follow-up in patients with mild to moderate acute ischemic stroke.
Keywords: depressive symptoms, stroke, poststroke depression, cerebral small vessel disease, white matter
hyperintensities, lacune, cerebral microbleeds, enlarged perivascular spaces
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INTRODUCTION
Poststroke depression (PSD) is associated with higher risk
of mortality, disability, and poor quality of life (Towfighi
et al., 2017). About one in three stroke survivors present
with PSD at any time after stroke (Towfighi et al., 2017).
Understanding the underlying pathophysiology of PSD may
facilitate developing better management strategies. Findings
concerning the relationship between stroke locations and PSD
have been inconsistent (Carson et al., 2000; Wei et al., 2015),
which challenges the hypothesis that PSD is caused by a
single lesion in the brain due to stroke (Stern and Bachman,
1991).
Cerebral small vessel disease (SVD) is a composite term for a
variety of chronic cerebral microvascular lesions resulting from
aging, vascular risk factors or unknown etiologies (Wardlaw
et al., 2013). SVD is common in aging and stroke populations
(Wardlaw et al., 2013). The most characteristic markers of
SVD on magnetic resonance imaging (MRI) are WMH, lacune,
cerebral microbleeds, and enlarged perivascular spaces (Wardlaw
et al., 2013). A “SVD score” that includes the above four
MRI markers was recently proposed to quantify the global
damage to the small vessels of the brain caused by SVD (Staals
et al., 2014). The SVD burden is associated with cognitive
decline in hypertension (Uiterwijk et al., 2016), poststroke
disability (Arba et al., 2017a), recurrence of stroke (Lau et al.,
2017), poor quality of life of stroke survivors (Liang et al.,
2017), and depression after lacunar stroke (Zhang X. et al.,
2017).
Individual SVD markers have been shown to be associated
with PSD (Santos et al., 2009a; Tang et al., 2014). Only one study
has reported an association between SVD burden and poststroke
depressive symptoms (PDS) 3 months after lacunar stroke (Zhang
X. et al., 2017). However, the impact of SVD burden on the longterm prevalence of PSD has never been investigated. Similarly,
the role of SVD burden in the development of PSD in a cohort
comprising all subtypes of acute ischemic stroke is unclear.
Hence, this study examined the association between SVD burden
and poststroke depressive symptoms (PDS) during the first
15 months following an acute ischemic stroke.

FIGURE 1 | Flow chart of the study.

Wales Hospital, Hong Kong, between January 2010 and October
2015. Due to the limited access to MRI, only 2,048 (32.1%) of all
admitted stroke patients underwent an MRI examination within
1 week of the onset of stroke. A further 1,339 (62.0%) were
excluded because they (1) refused to participate or were lost to
follow-up; (2) had a history of psychiatric or neurologic disorders;
(3) had severe comorbid medical conditions, such as multifunctional organs failure, cancer or severe systemic infection; (4)
had severe aphasia, auditory or visual impairments; (5) deceased
before the 15-month assessment; (6) had a recurrent stroke
during the 15-month follow-up; and (7) were not of Chinese
ethnicity.
The study protocol was approved by the Joint Chinese
University of Hong Kong New Territories East Cluster Clinical
Research Ethics Committee. All participants gave written
informed consent.

MATERIALS AND METHODS
Study Population
The recruitment of the study sample is depicted in Figure 1
where T0–T3 refer to assessment points at baseline, 3, 9, and
15 months after the index stroke, respectively. Patients with
first-ever or recurrent acute ischemic stroke were consecutively
screened following their admission to the Stroke Unit, Prince of

Demographic and Clinical Data
Within 1 week of the index admission (T0), demographic
(age, sex, and year of education) and clinical data on
vascular risk factors (smoking, history of hypertension, diabetes
mellitus, hyperlipidaemia, stroke, atrial fibrillation, and ischemic
heart disease) were collected. Baseline stroke severity was
assessed with the National Institutes of Health Stroke Scale
(NIHSS) (Brott et al., 1989) by a nurse from the Stroke
Unit. Physical and cognitive functions and level of social

Abbreviations: BI, Barthel Index; CI, confidence interval; GDS, Geriatric
Depression Scale; GEE, generalized estimating equation; IQR, interquartile ranges;
LSNS, Lubben Social Network Scale; MMSE, Mini–Mental State Examination;
MRI, Magnetic Resonance Imaging; NIHSS, National Institutes of Health Stroke
Scale; OR, odds ratio; PDS, poststroke depressive symptoms; PSD, poststroke
depression; SD, standard deviations; SVD, small vessel disease; WMH, white matter
hyperintensities.
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support were assessed by a research assistant with the
Barthel Index (BI) (Barthel, 1965), the Mini-Mental State
Examination (MMSE) (Chiu et al., 1994), and the Lubben Social
Network Scale (LSNS) (Lubben, 1988), respectively at T1, T2,
and T3.

TABLE 1 | Comparison of demographic, clinical and MRI characteristics between
the study sample and the patients withdrawn from the study.
Included

Withdrawn

(n = 563)

(n = 146)

Demographics

Study Outcomes
The primary study outcome was PDS at either T1, T2, or
T3. All patients were screened for PDS with the 15-item
Geriatric Depression Scale (GDS) by a psychiatrist (WKT). Clinically significant PDS suspect for an ongoing
depressive illness was defined by a score 7 or above
on the GDS (Tang et al., 2004a). The 15-item GDS has
good sensitivity (89%) and specificity (73%) in screening
for PDS in a Hong Kong stroke population (Tang et al.,
2004a).

Age, years, mean ± SD

67.0 ± 10.2

67.1 ± 11.4

Female sex, n (%)

230 (40.9)

52 (35.6)

Education, years, mean ± SD

6.7 ± 4.2

6.7 ± 5.1

Vascular risk factors, n (%)
Current or previous smoker

214 (38.0)

63 (42.9)

Hypertension

364 (64.7)

98 (67.6)

Hyperlipidemia

240 (42.6)

52 (35.9)

Diabetes mellitus

159 (28.2)

44 (30.3)

Previous stroke

56 (9.9)

19 (13.1)

Ischemic heart disease

26 (4.6)

8 (5.5)

Atrial fibrillation

24 (4.3)

16 (11.0)

NIHSS on admission, median (IQR)

3 (1–5)

3 (1–5)

Volume of acute infarcts, ml, mean ± SD

3.2 ± 9.6

3.5 ± 9.1

Number of acute infarcts, mean ± SD

1.3 ± 2.2

1.1 ± 1.1

Old infarcts, n (%)

114 (20.2)

58 (39.7)

Cortical

96 (17.1)

31 (21.2)

Subcortical white matter

173 (30.7)

36 (24.7)

Deep

127 (22.6)

31 (21.2)

Infratentorial

80 (14.2)

30 (20.5)

Stroke characteristics

Neuroimaging
All patients were scanned on a 1.5-T MRI system (Sonata;
Siemens Medical Systems Inc., Germany) with diffusion
weighted, gradient echo, T1- and T2-weighted and fluid
attenuated inversion recovery sequences. The MRI parameters
were described in detail elsewhere (Liang et al., 2017).
A qualified neurologist (YL) blind to all demographic and
clinical information reviewed the MRI data on SVD markers,
while another qualified neurologist (Y-KC) conducted the
measurement on infarcts. The numbers and volumes of acute
and old infarcts were recorded. The details of the scoring
method on ‘SVD burden’ were described earlier (Liang et al.,
2017). Briefly, based on a validated scale (Staals et al., 2014),
the presence of either lacune, cerebral microbleeds, extensive
WMH, or moderate to severe enlarged perivascular spaces
was awarded one point. Summing the above four subscores
produced a total SVD score ranging from 0 to 4. The interrater reliability of the MRI characteristics was determined by
comparing 30 randomly selected MRI scans rated separately
by YL and Y-KC. The inter-rater kappa coefficient values
were 0.76 for lacune; 0.63 for periventricular WMH, 0.62
for deep WMH; 0.78 for cerebral microbleeds, 0.80 for
enlarged perivascular spaces; and 0.66 for both acute and old
infarcts.

Location of acute infarcts, n (%)

SVD individual markers
Lacune, n (%)

113 (20.1)

28 (19.2)

Cerebral microbleeds, n (%)

76 (13.5)

29 (19.9)

Perivascular WMH, median (IQR)

1 (1–2)

1 (1–2)

Deep WMH, median (IQR)

1 (1–2)

1 (1–2)

Enlarged perivascular spaces, median (IQR)

1 (1–2)

1 (0–2)

SVD burden
SVD score, median (IQR)

1 (0–2)

1 (0–2)

SVD score = 0, n (%)

248 (44.0)

57 (39.0)

SVD score = 1, n (%)

134 (23.8)

30 (20.5)

SVD score = 2, n (%)

103 (18.3)

36 (24.7)

SVD score = 3, n (%)

54 (9.6)

15 (10.3)

SVD score = 4, n (%)

24 (4.3)

8 (5.5)

28.3 ± 8.4

28.5 ± 8.7

T1

103 (18.3)

20 (13.7)

T2

53 (11.6)

–

T3

69 (12.3)

–

T1

2 (1–5)

2 (1–4)

T2

2 (1–4)

–

T3

2 (1–4)

–

T1

19.1 ± 2.1

19.1 ± 1.9

T2

19.0 ± 2.3

–

T3

19.1 ± 2.1

–

26.9 ± 3.1

26.5 ± 3.4

Clinical assessments
Social support: LSNS, mean ± SD
PDS, n (%)

Statistical Analysis
SPSS Statistics, Version 20.0 software (IBM) was used for the
statistical analysis. Data are presented as mean ± standard
deviation (SD), median (interquartile range, IQR), or
proportions, as appropriate. The normality of the data
was tested with the Shapiro–Wilk test. To ascertain the
associations between SVD burden and PDS during the 15month follow-up, generalized estimating equation (GEE)
models were constructed by including patients attending
both the first (T1) and the last (T3) follow-ups (n = 563).
The summed and individual SVD scores were entered the
multivariate GEE models, adjusting for demographic, clinical
and imaging characteristics. The level of significance was set at
0.05 (two-tailed).
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TABLE 2 | Multivariate GEE model on the association between PDS and baseline
characteristics.

TABLE 1 | Continued
Included

Withdrawn

(n = 563)

(n = 146)

Significant predictorsa

T2

27.1 ± 3.2

–

Time points of assessments

T3

26.7 ± 3.7

–

T1

Reference

T2

0.60 (0.42–0.85)

0.004

T3

0.61 (0.45–0.82)

0.001

BI, Barthel Index; GDS, Geriatric Depression Scale; IQR, interquartile range;
LSNS, Lubben Social Network Scale; MMSE, Mini–Mental State Examination; MRI,
Magnetic Resonance Imaging; NIHSS, National Institutes of Health Stroke Scale;
PDS, poststroke depressive symptoms; SD, standard deviation; SVD, small vessel
disease; WMH, white matter hyperintensities.

OR (95%CI)

p

Sex
Male

Reference

Female

1.80 (1.02–3.17)

0.042

Smoking

RESULTS
Characteristics of the Study Sample
A total of 563 patients were enrolled at both T1 and T3;
146 (20.5%) patients defaulted at follow-up. Table 1 lists
the characteristics of the study sample and the patients who
defaulted. The stroke severity of the study sample was lower than
that of patients excluded from the study [NIHSS scores of 3 (1–5)
vs. 4 (1–11); p < 0.001; data not shown].
The demographic, clinical and imaging characteristics are
shown in Table 1. The study sample had a mean age of
67.0 ± 10.2 years; 40.9% were female. The stroke severity
was mainly mild to moderate with a median NIHSS score
of 3 (IQR, 1–5); 44.0% of the sample had no marked
SVD (SVD score = 0) while the median SVD score was
1 (IQR, 0–2). Levels of social support (LSNS: 28.3 ± 8.4),
functional independence (BI: 19.1 ± 2.1) and cognitive functions
(MMSE: 26.9 ± 3.1) were relatively high. The level of PDS
was low with a median GDS score of 2 across the three
assessments. The frequency of clinically meaningful PDS at
T1, T2, and T3 was 18.3% (103), 11.6% (53), and 12.4% (69),
respectively.

Reference

Current or previous smoker

1.75 (1.06–2.90)

0.029

Social support (LSNS)

0.96 (0.93–0.98)

<0.001

SVD burden (SVD score)

1.30 (1.07–1.58)

0.010

Number of acute infarcts

1.11 (1.02–1.20)

0.014

Functional independence (BI)

0.87 (0.81–0.92)

<0.001

BI, Barthel Index; CI, confidence interval; GEE, generalized estimating equation;
LSNS, Lubben Social Network Scale; OR, odds ratio; PDS, poststroke depressive
symptoms; SVD, small vessel disease.
a All the predictors listed here were adjusted for assessment time points, age,
sex, social support, vascular risk factors, stroke severity, location, number and
volume of acute infarcts, old infarcts, SVD burden, cognitive function, and functional
independence.

DISCUSSION
The main finding of this study is that SVD burden is associated
with clinically meaningful PDS over a 15-month follow-up period
in patients with mild to moderate acute ischemic stroke. To the
best of our knowledge, this was the first longitudinal study that
examined the relationship between SVD burden and PDS after
stroke.
It is of note that the SVD burden rather than any single
SVD marker was associated with PDS. Higher SVD burden is
associated with risk of depression 3 months after lacunar stroke
(Zhang X. et al., 2017). The current study extended this finding
by conducting a 15-month follow-up to ascertain the longterm impact of the baseline SVD burden on PDS. All subtypes
of ischemic stroke were included because lacunar strokes only
account for 25% of ischemic strokes (Kolominsky-Rabas et al.,
2001). Total SVD burden has been suggested to be a better
predictor of stroke outcomes, including mortality (Song et al.,
2017), disability (Arba et al., 2017a), stroke recurrence (Lau et al.,
2017), and poor quality of life (Liang et al., 2017), than a single
SVD marker. The findings of this study lend further support
to the hypothesis that chronic vascular burden in the brain is
a critical neuroanatomical factor in depression in older adults
(Santos et al., 2009b).
The underlying mechanisms linking SVD burden to
poststroke PDS are poorly understood. Functional disability
and cognitive impairment may be mediating factors as they
confer the highest risk for PSD (Towfighi et al., 2017). SVD
lesions reduce the brain’s ‘reserve’ against vascular insults and
its plasticity (Mok et al., 2017). Stroke patients with more
severe SVD are prone to have larger infarct volume (Helenius
et al., 2016), impaired reperfusion (Arba et al., 2017b), and

Association Between SVD and PDS
The results of the multivariate GEE model are shown in
Table 2. The combined SVD score (OR: 1.30, 95% CI: 1.07–
1.58; p = 0.010) was a significant predictor of PDS over
the 15-month follow-up. None of the four individual SVD
markers (lacune: p = 0.720; cerebral microbleeds: p = 0.066;
WMH: p = 0.430; enlarged perivascular spaces: p = 0.369) was
significantly associated with PDS in the multivariate GEE models
(data not shown).

Other Predictors of PDS
Other significant predictors of PDS were female sex (OR: 1.80,
95% CI: 1.02–3.17, p = 0.042); smoking (OR: 1.75, 95% CI:
1.06–2.90, p = 0.029); number of acute infarcts (OR:1.11, 95%
CI: 1.02–1.20, p = 0.014); time of assessment at T2 (OR:
0.60, 95% CI: 0.42–0.85, p = 0.004) and T3 (OR: 0.61, 95%
CI: 0.45–0.82, p = 0.001) compared with T1; higher level of
social support (OR: 0.96, 95% CI: 0.93–0.98, p < 0.001); and
functional independence (OR: 0.87, 95% CI: 0.81–0.92, p < 0.001)
(Table 2).
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In this study, the risk of PDS was decreasing during the
15-month follow-up. A one-year follow-up study reported that
the prevalence of depression decreased from 18.8% at 1 month
to 14.6% (Bour et al., 2010). A similar decline in PSD from
6.7% at 3 months to 5.1% at 1 year has also been reported
(Kulkantrakorn and Jirapramukpitak, 2007). The number of
acute infarcts predicted PDS in the present study, which is
consistent with the finding that more severe lacunar infarcts are
associated with PSD (Santos et al., 2009a; Wu et al., 2014).
The major strengths of this study are its prospective design,
large sample size and its relatively long 15-month followup after the index stroke. The first major limitation is that
this study mainly included mild to moderate stroke patients.
This selection bias reduces the generalizability of the results,
including the relationship of SVD burden and PDS in acute
ischemic stroke. Second, the lack of comprehensive clinical
assessment of depression limits the clinical implications of the
study, although PDS also have detrimental effects on stroke
outcomes (Towfighi et al., 2017). Nevertheless, the GDS is a
reliable tool to detect PDS in this stroke population and has
been shown to be useful for screening PDS in Hong Kong
elderly stroke patients with good sensitivity and specificity (Tang
et al., 2004a,b). A systemic review has also confirmed that
the GDS could detect milder PDS in the elderly (Burton and
Tyson, 2015). The third limitation is the lack of etiological
differentiation of ischemic stroke due to the limited clinical
information. Hence, the study could not clarify the differential
impact of SVD burden on PDS with respect to the subtypes
of acute ischemic stroke. Fourth, about a quarter of eligible
patients were lost to follow-up. To offset this limitation, GEE
analysis was used to handle missing data. Fifth, this was an
observational study without comprehensive investigation of the
inflammatory markers or comorbidities. Moreover, we are aware
that ideally the assessment of imaging data should be conducted
by two raters despite of moderate to good interrater agreements,
however, this study failed to provide confirming assessments
by a second rater due to the limited manpower. Finally, the
15-month follow-up could not draw conclusions about the
association between SVD burden and longer-term clinical course
of PDS.

recurrent stroke (Lau et al., 2017). Consequently, disability
and cognitive decline were more likely to occur among stroke
survivors with severe SVD burden (Huijts et al., 2013; Arba
et al., 2017a). However, after adjustment for acute infarcts,
stroke severity, functional independence, and cognition in
this study, SVD burden remained a significant predictor of
PDS. This suggests that SVD burden might contribute to
the development of PDS via other paths. From a network
viewpoint, the integrity of both the structural and functional
global network is the key prerequisite for recovery from stroke
(Lim and Kang, 2015) and emotional modulation (Gong and
He, 2015). SVD leads to the disruption of white matter integrity
of frontal-subcortical circuit which is thought to be critical in
the pathogenesis of depression (van Uden et al., 2015). Reduced
global structural network efficiency arising from SVD has
recently been shown to be associated with depression (Xie et al.,
2017).
The pathomechanism of PSD is not yet clarified. In addition
to the ‘vascular depression hypothesis’ as mentioned above,
evidence is emerging to support the notion that inflammation
could also play a role in the development of PSD (Popa-Wagner
et al., 2014; Becker, 2016). Higher level of inflammatory markers
was recently found to be predictor of PSD (Cheng et al., 2017)
and anti-inflammatory treatment has shown promising results in
reducing risk of PSD (Wium-Andersen et al., 2017). Furthermore,
SVD burden was found to be associated with systemic lupus
erythematosus, a systemic inflammatory disease (Wiseman et al.,
2016). Enlarged perivascular spaces, one of the SVD markers,
was proposed as an MRI marker of neuroinflammatory activity
and was associated with lesions in multiple sclerosis (Wuerfel
et al., 2008). The above findings suggest that SVD burden
could be an epiphenomenon of the accumulating inflammatory
processes.
Medical comorbidities are the ‘silent contributors’ to stroke
outcomes (Sandu et al., 2015). Intracranial atherosclerosis and
diabetes were recently reported to be risk factors of early-onset
and late-onset PSD, respectively (Chen et al., 2016; Zhang Y.
et al., 2017); smoking, as also demonstrated in this study, was
associated with PDS. It is suggested that these comorbidities join
SVD to promote a chronic proinflammatory state and fuel acute
neuroinflammation in the event of acute stroke (Di Napoli et al.,
2012; Sandu et al., 2015). The aggravated neuroinflammation,
in turn, causes the downstream neurodegeneration, neuronal
apoptosis, and impaired neuroplasticity (Leonard and Maes,
2012), disrupt the depression-related neurocircuits (Loubinoux
et al., 2012), and eventually result in depressive symptoms or
other unfavorable outcomes (Di Napoli et al., 2012). Taken
together, PSD or PDS could be viewed as a consequence of a
complex interplay between stroke, pre-stroke comorbidities, and
neuroinflammation (Sandu et al., 2015).
Other predictors of PDS in the present study were female
sex, lower levels of functional independence and social support,
smoking, the time of the assessment, and the number of acute
infarcts. Female sex, lower level of functional independence and
social support have been consistently reported as risk factors of
PSD (Towfighi et al., 2017). Smoking also increases the risk of
PSD in minor stroke (Shi et al., 2015).
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CONCLUSION
SVD burden was associated with clinically significant PDS
over a 15-month follow-up in patients with mild to moderate
acute ischemic stroke. The findings lend further support to the
hypothesis of vascular depression suggesting that accumulating
microvascular lesions are critical for the development of
depressive symptoms. Measurement of SVD burden might
facilitate the early identification of patients at risk of PDS
after mild to moderate acute ischemic stroke. Multimodal
imaging studies from a network perspective would be
useful to clarify the underlying mechanisms linking SVD
to PDS. Investigations of the impact of SVD burden on the
effectiveness of antidepressant treatment in PDS are also
warranted.
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that questions related to the accuracy or integrity of
any part of the study are appropriately investigated and
resolved.
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